Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study

• Main Authors: Zhuangzhuang Zheng (Author), Zijing Liu (Author), Haifeng Zhang (Author), Xiao Guo (Author), Xiaojing Jia (Author), Jianfeng Wang (Author), Lingbin Meng (Author), Ying Xin (Author), Xin Jiang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and Purpose: Apatinib is a novel antiangiogenic agent that can target vascular endothelial cell growth factor 2. The aim of our study was to evaluate the efficacy and safety of apatinib mesylate in the treatment of advanced hepatocellular carcinoma (HCC) in the real world.Methods: We retr...